Fundraising Fox
/Investor DB
Sign in

SPARX Group — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Provigate, Inc.provigate.cominSep 2021

Provigate develops a low/non-invasive, low-cost home glucose monitoring service based on weekly glycated albumin (GA) testing from finger-prick blood or saliva samples via mail-in and point-of-care testing, paired with a coaching app and a remote monitoring dashboard for clinicians.

BiotechDigital HealthMedical DevicesTokyo, JP

Koshin Sekimizu, PhD(Founder)in

Co-investorsCoral CapitalANRI

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.